Pacifica Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Pacifica Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150	Closed	-$9.87K	–	492
2025 Q3	$9.87K	Hold	150	–	–	﹤0.01%	333
2025 Q2	$5.97K	Hold	150	–	–	﹤0.01%	378
2025 Q1	$4.28K	Hold	150	–	–	﹤0.01%	391
2024 Q4	$5.2K	Hold	150	–	–	﹤0.01%	366
2024 Q3	$6.01K	Hold	150	–	–	﹤0.01%	383
2024 Q2	$6.84K	Hold	150	–	–	﹤0.01%	387
2024 Q1	$6.58K	Hold	150	–	–	﹤0.01%	392
2023 Q4	$7.5K	Hold	150	–	–	﹤0.01%	401
2023 Q3	$7.03K	Hold	150	–	–	﹤0.01%	384
2023 Q2	$6.33K	Hold	150	–	–	﹤0.01%	345
2023 Q1	$5.57K	Hold	150	–	–	﹤0.01%	373
2022 Q4	$5.58K	Hold	150	–	–	﹤0.01%	341
2022 Q3	$6K	Hold	150	–	–	﹤0.01%	349
2022 Q2	$6K	Hold	150	–	–	﹤0.01%	351
2022 Q1	$5K	Hold	150	–	–	﹤0.01%	373
2021 Q4	$5K	Hold	150	–	–	﹤0.01%	363
2021 Q3	$5K	Hold	150	–	–	﹤0.01%	360
2021 Q2	$6K	Hold	150	–	–	﹤0.01%	336
2021 Q1	$7K	Hold	150	–	–	0.01%	297
2020 Q4	$9K	Hold	150	–	–	0.01%	258
2020 Q3	$7K	Hold	150	–	–	0.01%	252
2020 Q2	$9K	Hold	150	–	–	0.01%	239
2020 Q1	$8K	Hold	150	–	–	0.01%	251
2019 Q4	$9K	Buy	+150	New	+$8.94K	0.01%	245

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Pacifica Partners's IONS Position: Q4 2025 in Review

Pacifica Partners sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 150 shares — an estimated $9.87K sold.

Pacifica Partners first reported a position in IONS in Q4 2019 and held it in 24 quarters. The position peaked at $9.87K in Q3 2025. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

Pacifica Partners reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Pacifica Partners sold 150 Ionis Pharmaceuticals shares in Q4 2025, an estimated $9.87K.
Pacifica Partners first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 24 quarters.
Pacifica Partners's Ionis Pharmaceuticals position peaked at $9.87K in Q3 2025.
491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Pacifica Partners's 13F filing for Q4 2025, filed 9 Jan 2026.